Federal Court, Not DEA Hearing Room, May Decide Marijuana Rescheduling's Legal Fate
The DEA's marijuana rescheduling hearing, set for June 29, has drawn intense attention from cannabis operators, investors, and compliance professionals watching for signs of what a Schedule III
Missouri Opens Lottery Window for 77 Microbusiness Cannabis Licenses This July
Missouri is preparing to open a two-week application window - July 13 through July 27 - for prospective licensees seeking one of 77 microbusiness marijuana licenses that will be awarded by lottery.
Summer Solstice Heat Forces Cannabis Dispensaries to Rethink Cold-Chain Operations
The summer solstice arrives with more than just longer days. For licensed cannabis retailers and their supply chain partners, the seasonal shift to peak solar intensity brings real operational
South Dakota City Cuts Cannabis Licensing Fees to Stay Competitive
Brandon, South Dakota has moved to lower two of its cannabis licensing requirements - the annual renewal application fee and the minimum liability insurance threshold - after a local cultivator
Trulieve Authorizes $50 Million Share Buyback, Signaling Confidence in Its Own Valuation
Trulieve Cannabis Corp. has authorized a share repurchase program of up to $50 million - or up to 5% of its issued and outstanding subordinate voting shares, whichever is smaller - over the next 12
Michigan Regulator Files Complaint Against Processor Holding Thousands of Untagged Products
A Michigan cannabis processor is facing potential license suspension after state inspectors found more than 12,000 individual cannabis products with no Metrc tags or identifying information -
DOT Confirms Schedule III Shift Does Not Shield Workers From Marijuana Testing
The Department of Transportation's Office of Drug and Alcohol Policy and Compliance issued formal guidance on May 15, 2026, making one thing unmistakably clear: the DOJ's reclassification of certain
Federal Cannabis Rescheduling Reshapes Tax Rules While Operators Wait for Clarity
The Justice Department's decision to move medical cannabis from Schedule I to Schedule III under the Controlled Substances Act is the most significant shift in federal drug policy in decades - and
Green Cross Health Shows Why Profitable Cannabis Retailers Attract Serious B2B Attention
Profitability is a rare and underappreciated asset in regulated cannabis retail - and Green Cross Health (NZSE: GXH) is making a credible case for why it matters. The New Zealand-listed operator has
Three State AGs Sue to Block Federal Marijuana Rescheduling Before It Takes Effect
Indiana Attorney General Todd Rokita has joined his counterparts in Nebraska and Louisiana in a federal lawsuit seeking to stop the U.S. Department of Justice from moving marijuana from Schedule I to